FDA Inspection
Delta Pharma, Inc.Delta Pharma, Inc. – FDA Inspection, Feb 23, 2017
Record Details
This FDA Inspection record concerns Delta Pharma, Inc., with an inspection on February 23, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 734f2b2a-b199-48d2-8e52-c626e2160842
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1004804
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Delta Pharma, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | New Orleans District Office | Drug Quality Assurance |
| April 12, 2024 | Not classified | New Orleans District Office | Drug Quality Assurance |
| June 2, 2023 | VAI | New Orleans District Office | |
| May 20, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Delta Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.